Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Might Be Cheaper Than You Think
Motley Fool
Wednesday, September 8, 2010 - 1:52pm
tags:
Pfizer
ZymoGenetics shares soar 84 percent
Bizjournals.com
Wednesday, September 8, 2010 - 1:41pm
tags:
ZymoGenetics, Bristol-Myers Squibb, M&A
Elan CEO Condemns ‘Falsehoods And Insinuations’
Pharmalot
Wednesday, September 8, 2010 - 11:38am
tags:
Elan, Pharma CEOs, Kelly Martin
Biggest Battles in Biopharma
Fierce Pharma
Wednesday, September 8, 2010 - 11:33am
tags:
Sun Pharma, Taro, Pfizer, Warner-Lambert, Aventis, Sanofi-Synthelabo, Astellas, OSI Pharmaceuticals, King, Alpharma, Novartis, Carl Icahn, Bristol-Myers Squibb, Alcon, Genzyme
Shionogi cutting 350 reps as Biovail boosts layoffs
Fierce Pharma
Wednesday, September 8, 2010 - 11:30am
tags:
layoffs, Shionogi, Biovail
How Merck Bet $2.6B on a Technicality
BNET Pharma
Wednesday, September 8, 2010 - 11:12am
tags:
Merck, Remicade, JNJ, Schering Plough
Business confidence higher in pharma sector - report
Pharma Times, UK
Wednesday, September 8, 2010 - 11:11am
tags:
pharma industry
U.S. court orders Teva to pay $365m to Hepatitis C-infected man
Haaretz.com
Wednesday, September 8, 2010 - 11:09am
tags:
Teva Pharmaceuticals, hepatitis C, settlements, propofol, Baxter International
Appeals Court Upholds Pay-To-Delay Deals, Again
Pharmalot
Wednesday, September 8, 2010 - 11:06am
tags:
pay-for-delay, FTC
Abbott Laboratories completes Piramel unit buyout
Yahoo/AP
Wednesday, September 8, 2010 - 11:05am
tags:
M&A, Abbott Laboratories, Piramal Healthcare, India
Onyx Sells Japan Rights to Blood Cancer Drug
TheStreet.com
Wednesday, September 8, 2010 - 7:36am
tags:
ONYX Pharmaceuticals, Japan, Ono, Carfilzomib
Gilead: Is This Cash Machine Running on Empty?
Motley Fool
Wednesday, September 8, 2010 - 7:23am
tags:
Gilead Sciences
Sanofi's CEO Viehbacher Pitches Genzyme Investors on Bid
Bloomberg
Wednesday, September 8, 2010 - 6:29am
tags:
Pharma CEOs, Chris Viehbacher, M&A, Genzyme, Sanofi
Forest Labs says panel supports its antibiotic
Yahoo/AP
Wednesday, September 8, 2010 - 6:27am
tags:
Forest Labs, advisory panels, antibiotics, FDA, ceftaroline
Bristol-Myers Agrees to Acquire ZymoGenetics for $885 Million
NY Times, NY
Tuesday, September 7, 2010 - 9:29pm
tags:
Bristol-Myers Squibb, M&A, ZymoGenetics
Merck schizophrenia drug approved for 2 new uses
Yahoo/AP
Tuesday, September 7, 2010 - 5:04pm
tags:
Merck, schizophrenia, FDA, Saphris, mania, bipolar disorder
Teva Wins Copaxone Protection
Forbes
Tuesday, September 7, 2010 - 5:03pm
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis, patents, Novartis, Momenta
Vertex Cures Hard-to-Treat Hep C Patients
TheStreet.com
Tuesday, September 7, 2010 - 5:01pm
tags:
Vertex Pharmaceuticals, hepatitis C, Telaprevir
Allergan Directors Are Sued Over Marketing of Botox
Bloomberg
Tuesday, September 7, 2010 - 2:02pm
tags:
Botox, Allergan, lawsuits, off-label
'Multiple Shrinkage' Weighs on Large-Cap Biotech
TheStreet.com
Tuesday, September 7, 2010 - 1:12pm
tags:
biotech, Amgen, Celgene, Biogen Idec, Gilead Sciences, Genzyme

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.